Discovery of 4-methyl-3-(pyridin-2-ylamino)benzamide derivatives as C-Abl inhibitors with potential neuroprotective effect
- 19 October 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 74, 117069
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21603095)
- Guangdong Provincial Key Laboratory of Construction Foundation (2017B030314030, 2020B1212060034)
This publication has 34 references indexed in Scilit:
- Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?International Journal of Cell Biology, 2012
- c-Abl in Neurodegenerative DiseaseJournal of Molecular Neuroscience, 2011
- Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's DiseaseJournal of Neuroscience, 2011
- c-Abl tyrosine kinase in the DNA damage response: cell death and moreCell Death & Differentiation, 2010
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective functionProceedings of the National Academy of Sciences, 2010
- Improved side‐chain torsion potentials for the Amber ff99SB protein force fieldProteins: Structure, Function, and Bioinformatics, 2010
- Integrin-Mediated Dendrite Branch Maintenance Requires Abelson (Abl) Family KinasesJournal of Neuroscience, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP modelThe Journal of Physical Chemistry, 1993
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983